RECRO PHARMA INC (REPH) Stock Earnings & Estimates
NASDAQ:REPH - Common Stock
2.09
-0.01 (-0.48%)
2.09
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 99.22M 28.27% | 66.5M -32.98% | 75.36M 13.32% | 93.25M 23.74% | 102.149M 9.54% | 116.323M 13.88% | 135.113M 16.15% | |
| EBITDA YoY % growth | 32.03M 169.34% | 200K -99.38% | 7.98M 3,890.00% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 23.63M 143.73% | -8.34M -135.29% | 412K 104.94% | N/A | N/A | N/A | N/A | |
| Operating Margin | 23.82% | -12.54% | 0.55% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | 0.20 108.03% | -1.15 -675.00% | -0.31 73.04% | -0.29 5.68% | -0.24 16.28% | -0.27 -8.71% | -0.30 -10.89% |
| Q1 / 22 | Q2 / 22 | Q3 / 22 | Q4 / 22 | Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.08 63.04% | -0.04 -224.68% | -0.05 22.29% | -0.05 -35.99% | -0.09 -8.00% | -0.02 45.46% | -0.04 25.00% | -0.04 25.00% |
| Revenue Q2Q % growth | 19.807M 17.90% | 25.556M 41.84% | 24.192M 32.65% | 24.397M 9.39% | 21.379M 7.94% | 28.002M 9.57% | 25.99M 7.43% | 26.267M 7.67% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | -0.04 91.67% | -0.07 | 0.03 | 41.18% |
| Q3 2021 Q2Q % growth | -0.07 22.22% | -0.07 | 0.00 | 6.41% |
| Q2 2021 Q2Q % growth | 0.03 112.00% | -0.11 | 0.14 | 126.74% |
| Q1 2021 Q2Q % growth | -0.23 30.30% | -0.26 | 0.03 | 11.57% |
| Q4 2020 Q2Q % growth | -0.48 -178.69% | -0.22 | -0.26 | -113.90% |
| Q3 2020 Q2Q % growth | -0.09 52.63% | -0.21 | 0.12 | 56.96% |
| Q2 2020 Q2Q % growth | -0.25 -92.31% | -0.16 | -0.09 | -53.19% |
| Q1 2020 Q2Q % growth | -0.33 -266.67% | -0.03 | -0.30 | -870.69% |
| Q4 2019 Q2Q % growth | 0.61 | -0.26 | 0.87 | 336.85% |
| Q3 2019 Q2Q % growth | -0.19 | -0.21 | 0.02 | 9.58% |
| Q2 2019 Q2Q % growth | -0.13 | -0.43 | 0.30 | 69.65% |
| Q1 2019 Q2Q % growth | -0.09 | -1.08 | 0.99 | 91.70% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | 22.303M 125.06% | 21.84M | 462.76K | 2.12% |
| Q3 2021 Q2Q % growth | 18.237M -5.46% | 18.433M | -196.103K | -1.06% |
| Q2 2021 Q2Q % growth | 18.017M 16.09% | 17.439M | 577.55K | 3.31% |
| Q1 2021 Q2Q % growth | 16.8M -22.87% | 16.76M | 40.38K | 0.24% |
| Q4 2020 Q2Q % growth | 9.91M -43.82% | 15.296M | -5.386M | -35.21% |
| Q3 2020 Q2Q % growth | 19.29M -23.63% | 16.653M | 2.637M | 15.83% |
| Q2 2020 Q2Q % growth | 15.52M -50.35% | 19.255M | -3.735M | -19.40% |
| Q1 2020 Q2Q % growth | 21.78M -13.12% | 19.836M | 1.944M | 9.80% |
| Q4 2019 Q2Q % growth | 17.64M | 19.938M | -2.298M | -11.52% |
| Q3 2019 Q2Q % growth | 25.26M | 20.759M | 4.501M | 21.68% |
| Q2 2019 Q2Q % growth | 31.26M | 24.061M | 7.199M | 29.92% |
| Q1 2019 Q2Q % growth | 25.07M | 20.917M | 4.153M | 19.85% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |